145 145 (Rivastigmine Tartrate 1.5 mg)
Pill with imprint 145 145 is Yellow, Capsule-shape and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Sun Pharmaceutical Industries Inc..
Rivastigmine is used in the treatment of alzheimer's disease; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 145 145
Rivastigmine Tartrate
- Imprint
- 145 145
- Strength
- 1.5 mg
- Color
- Yellow
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cholinesterase inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceutical Industries Inc.
- Inactive Ingredients
-
magnesium stearate, microcrystalline cellulose, silicon dioxide, gelatin, titanium dioxide, D&C Red No. 28, D&C Yellow No. 10, FD&C Yellow No. 6, shellac, alcohol, butyl alcohol, propylene glycol, ammonia, potassium hydroxide, ferrosoferric oxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 62756-0145 | Sun Pharmaceutical Industries Inc. |
| 68084-0550 | Amerisource Health Services |
Related Images for "145 145"
More about rivastigmine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- 29 Reviews
- Drug class: cholinesterase inhibitors
Consumer resources
- Rivastigmine
- Rivastigmine transdermal
- Rivastigmine (Advanced Reading)
- Rivastigmine Transdermal (Advanced Reading)
- Rivastigmine Capsules
- ... +2 more
Other brands: Exelon
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
